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Introduction

Results

G-quadruplex (G4) DNA are non-canonical higher order DNA structures formed
from guanine rich sequences, made up of stacked G-tetrads stabilized by
non-Watson-Crick (Hoogsteen) base pairing and K+ ions.
Early interests in G4 DNA were spurred on by the revelation that G4 was formed in
telomeric DNA sequences at the end of our chromosomes. This was particularly
promising given that G4 structures formed in telomeric DNA were also found to inhibit
an enzyme known as telomerase, which is overexpressed (>90%) in cancer cells. Cancer
cells require telomerase activity for survival and “immortality”, therefore stabilization
of telomeric G4 can inhibit telomerase activity and prevent the survival of cancer cells.
More recently, G4 DNA has also been shown to be overrepresented in the promoter
regions of oncogenes (e.g., c-MYC and ras genes) and the 5’UTR of mRNA. As a result,
G4 DNA represents a viable target for possible anti-cancer therapeutic agents to treat
previously “undruggable” sites such as the c-MYC and ras oncogenes1.

Validation of G4 Structure

Thioflavin Displacement of NDI7 and TMPYP4

In this work, G4 structures formed at both human telomeric and c-MYC sequences will
be investigated by targeting/probing them using a variety of known and novel
compounds. Using biophysical techniques such as fluorescent displacements assays,
thermal melting, and circular dichroism (CD) spectroscopy, the binding characteristics
of these compounds to G4 DNA will be investigated for their efficacy as a possible
anti-cancer therapeutic strategy.

Figure 3. Thermal melting of G4 structure with varying level of ion
concentration (left). Circular dichroism with varying level of ion
concentration (right).

Figure 4. Thioflavin-T fluorescence displacement
assays of G4 DNA with TMPYP4 and NDI7.

Thermal Melting of c-MYC DNA

CD Spectroscopy of c-MYC DNA
Figure 1. A simple diagram demonstrating the mechanism of the Thioflavin-T displacement assay,
Adapted from Jamroskovic et al2

Figure 5. Circular Dichroism spectroscopy of c-MYC DNA compared to a buffer

Figure 2. A simplified diagram of DNA G-quadruplexes formed from human
telomeric DNA3 .

Experimental
Sample Preparation
DNA G-Quadruplexes were formed in solution using a 10 mM phosphate buffer, pH 7, with 100mM K + added.
Characteristic CD spectra confirmed the presence of quadruplexes in solution.
Thioflavin-T Fluorescence Displacement
Fluorescent studies were performed using a PTI Quantamaster™ 40 UV-Vis Spectrofluorometer from 400-600nm.
A Fluorogenic dye that binds specifically to DNA G-quadruplexes, Thioflavin-T (Tht), was used as a fluorescent
indicator for the quadruplexes. A solution of Tht-bound G-quadruplexes was prepared and the drug of interest was
added. The solution was excited at 425 nm and fluorescence intensity was measured.
Circular Dichroism
Circular dichroism was performed using a Jasco-815 spectropolarimeter on myc-DNA, and myc-buffer from ranges
of 200-400 nm.
Thermal Melting
Thermal melting was conducted using Varian Cary 5000 UV-vis spectrophotometer from a range of 25-95 degrees
celsius. The samples assessed included: c-MYC only, c-MYC with ThT, c-MYC with the porphyrin compound TMPYP4,
C-MYC with a disubstituted naphthalene diimide (NDI7).

Figure 6. Thermal melting spectroscopy of c-MYC DNA and c-MYC DNA with ThT

Conclusions
• CD Spectroscopy and Thermal Melting data from previous research students confirmed the formation of telomeric G4 DNA and an ion concentration of 100mM was
the most effective concentration to form these structures
• ThT displacement assays demonstrated both TMPYP4 and NDI7 bind to G4 successfully and displace ThT. Between TMPYP4 and NDI7, TMPYP4 has a higher binding
affinity
• CD Spectroscopy comparing buffer and c-MYC DNA showed the successful creation of c-MYC G4 structures
• Thermal Melting confirmed the presence of c-MYC G4 structures, and ThT has the ability to bind to and stabilize these structures

Future Research
• Now that we have confirmed we created G4 c-MYC DNA, we plan to investigate the interaction of other drugs (currently in our lab, eg., additional NDI derivatives,
quinacrine) with this DNA and determine whether these drugs stabilize the G4 structure
• If we can determine a drug that can target and stabilize the G4 c-MYC DNA, we may be able to use it as an anticancer approach
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